Julian, Elaine; Gianfrate, Fabrizio; de Sola-Morales, Oriol - In: Health Economics Review 12 (2022) 1, pp. 1-12
drivers in HTAs today (scale 1, low to 5, high) were clinical trial design (mean 4.45), right endpoints (mean 4.40), and size …-relevant endpoints; and a transparent and consistent management of both HTA and regulatory procedures as well as their interface …